Lapides Asset Management, LLC - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 53 filers reported holding PSYCHEMEDICS CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Lapides Asset Management, LLC ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q3 2021$137,000
+18.1%
16,300
-2.4%
0.06%
+23.9%
Q2 2021$116,000
-12.1%
16,700
-21.6%
0.05%
-16.4%
Q1 2021$132,000
+112.9%
21,300
+74.6%
0.06%
+103.7%
Q4 2020$62,000
-39.2%
12,200
-47.4%
0.03%
-51.8%
Q3 2020$102,000
-1.0%
23,200
+24.7%
0.06%
-6.7%
Q2 2020$103,000
-52.1%
18,600
+73.8%
0.06%
+50.0%
Q1 2017$215,000
+87.0%
10,700
-5.3%
0.04%
+100.0%
Q4 2015$115,000
+3.6%
11,300
+2.7%
0.02%
+5.3%
Q3 2015$111,00011,0000.02%
Other shareholders
PSYCHEMEDICS CORP shareholders Q1 2017
NameSharesValueWeighting ↓
22NW, LP 274,418$1,089,4390.78%
WEALTH EFFECTS LLC 40,701$161,5820.08%
Cannell Capital 74,794$296,9320.07%
SANTA MONICA PARTNERS LP 20,000$790.06%
RBF Capital, LLC 144,231$572,5970.04%
WEDBUSH SECURITIES INC 42,414$1680.01%
Ancora Advisors LLC 78,373$311,1410.01%
Your Advocates Ltd., LLP 1,400$5,5580.00%
CRAWFORD INVESTMENT COUNSEL INC 32,098$127,4280.00%
Renaissance Technologies 273,663$1,0860.00%
View complete list of PSYCHEMEDICS CORP shareholders